INDP vs LYB · $7.4M cap vs P/E 21, rev $40.30B
Indaptus Therapeutics Inc (INDP) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Indaptus Therapeutics Inc (INDP) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
INDP does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
INDP currently screens at market cap $7.4M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the INDP and LYB stock pages for the full models.
Not investment advice.